PHARMACOLOGICAL CLASSIFICATION:
A.22. 1.4 - Vitamins: Others
INDICATIONS:
NEUROBION tablets are indicated where a deficiency of the relevant vitamins exists.
CONTRA-INDICATIONS:
NEUROBION should not be used in patients on Levodopa therapy.
Hypersensitivity to any of the above ingredients.
DOSAGE AND DIRECTIONS FOR USE:
NEUROBION tablets may be administered in a dosage of 1 daily.
SIDE-EFFECTS AND SPECIAL PRECAUTIONS:
Cyanocobalamin should not be given before a diagnosis has been fully established because of the possibility of masking
symptoms of subacute degeneration of the spinal cord.
Cyanocobalamin is not a suitable form of vitamin B12 for the treatment of optic neuropathies associated with raised
plasma concentrations of cyanocobalamin.
KNOWN SYMPTOMS OF OVERDOSAGE AND PARTICULARS OF ITS TREATMENT:
Treatment is symptomatic and supportive.
IDENTIFICATION:
White, shiny, round coated tablets, steeply convexed on both sides.
PRESENTATION:
Amber glass bottles containing 30 tablets.
STORAGE INSTRUCTIONS:
Store at or below 25 ·c.
KEEP OUT OF REACH OF CHILDREN.
REFERENCE NUMBER:
H2487 (Act 101/1965).
NAME AND BUSINESS ADDRESS OF THE APPLICANT:
Merck (Pty) Ltd
1 Friesland Drive
Longmeadow Business Estate South
Modderfontein, 1645
DATE OF PUBLICATION OF THIS PACKAGE INSERT:
11 March 1988
You are about to leave the Neurobion® South African website and will be redirected to an external website. Would you like to leave?